These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5521334)

  • 21. TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.
    MACBETH WA; KASS EH; MCDERMOTT WV
    Lancet; 1965 Feb; 1(7382):399-403. PubMed ID: 14238091
    [No Abstract]   [Full Text] [Related]  

  • 22. Kanamycin and neomycin.
    Med Lett Drugs Ther; 1967 Aug; 9(16):61-3. PubMed ID: 6034879
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapy of portal-systemic encephalopathy: the practical and the promising.
    Weber FL
    Gastroenterology; 1981 Jul; 81(1):174-7. PubMed ID: 7239116
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serotonin stimulation of adenylate deaminase activity].
    Gridneva LI; Suvorov NN; Gorkin VZ
    Biull Eksp Biol Med; 1974 Jul; 78(7):56-8. PubMed ID: 4451716
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of modifying urea hydrolysis in acute nephrectomy on survival, ammonia in cecal contents and blood metabolites.
    Prior RL; Visek WJ
    Proc Soc Exp Biol Med; 1973 Oct; 144(1):184-8. PubMed ID: 4771557
    [No Abstract]   [Full Text] [Related]  

  • 26. [Significance of fecal Bacteroides in hepatic encephalopathy with hyperammonemia].
    Tarao K
    Kansenshogaku Zasshi; 1986 Jan; 60(1):15-24. PubMed ID: 3088172
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of oral neomycin and kanamycin in chronic uremic patients: I. Urea metabolism.
    Mitch WE; Lietman PS; Walser M
    Kidney Int; 1977 Feb; 11(2):116-22. PubMed ID: 846062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
    Bongaerts G; Severijnen R; Timmerman H
    Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
    Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of neomycin in the treatment of acute hepatoportal encephalopathy].
    Gubskiĭ LV; Ershov IuA
    Klin Med (Mosk); 1976 Apr; 54(4):110-5. PubMed ID: 1016352
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids.
    Chalasani N; Gitlin N
    Am J Gastroenterol; 1996 Jun; 91(6):1266-8. PubMed ID: 8651189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 33. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
    Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
    Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Critical study of venous blood ammonia in hepatic coma. Diagnosis, surveillance and treatment].
    Dupuy R; Thiroloix J
    Rev Int Hepatol; 1967; 17(1):43-53. PubMed ID: 6060728
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatic coma. Principles of pathogenesis and treatment. 2: Treatment, prognosis].
    Müting D; Reikowski J
    Fortschr Med; 1983 Oct; 101(39):1766-73. PubMed ID: 6642382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of antibiotics in the management of hepatic encephalopathy.
    Maddrey WC
    Rev Gastroenterol Disord; 2005; 5 Suppl 1():S3-9. PubMed ID: 15976746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment with aspartic acid in hepatic coma caused by hyperammonemia].
    Fodor O; Popescu S; Grigoraş D; Barbarino F
    Med Interna (Bucur); 1968 Jul; 20(7):781-5. PubMed ID: 5685308
    [No Abstract]   [Full Text] [Related]  

  • 38. Alteration of fecal bacterial flora following oral administration of bifidobacterial preparation.
    Tamura N; Norimoto M; Yoshida K; Hirayama C; Nakai R; Takagi A
    Gastroenterol Jpn; 1983 Feb; 18(1):47-55. PubMed ID: 6832549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of anaerobic gram-negative bacteria in hepatic encephalopathy and the therapeutic effects of vancomycin hydrochloride on hepatic encephalopathy].
    Tarao K; Ikeda T; Hayashi K; Sakurai A
    Nihon Shokakibyo Gakkai Zasshi; 1985 Aug; 82(8):1875-83. PubMed ID: 4068308
    [No Abstract]   [Full Text] [Related]  

  • 40. SOME EFFECTS OF INDUCTION OF UREASE IMMUNITY IN PATIENTS WITH HEPATIC INSUFFICIENCY.
    THOMSON A; VISEK WJ
    Am J Med; 1963 Dec; 35():804-12. PubMed ID: 14089297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.